Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections

4 Jul 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Pneumonia and Respiratory Infections

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35781869
DOI: 10.1007/s15010-022-01876-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infectionsPMID 35781869Read ↗

Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative BacteriaSemantic proximity Read ↗

Resistance to ceftazidime–avibactam and underlying mechanismsSemantic proximity Read ↗

Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates from United States Medical Centers in 2016-2018.Semantic proximity Read ↗

Molecular mechanisms underlying bacterial resistance to ceftazidime/avibactamSemantic proximity Read ↗

Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical LaboratorySemantic proximity Read ↗

The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Semantic proximity Read ↗

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infectionsSemantic proximity Read ↗

Treatment of Infections Due to MDR Gram-Negative BacteriaSemantic proximity Read ↗

Developments on antibiotics for multidrug resistant bacterial Gram-negative infectionsSemantic proximity Read ↗

Ceftazidime-Avibactam Use in a Cohort of Children with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development Following Difficult-to-Treat or Recurrent InfectionsSemantic proximity Read ↗

Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in ChildrenSemantic proximity Read ↗

Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing EnterobacteriaceaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.